⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INCY News
Incyte Genomics Inc
Incyte annuncia l'approvazione da parte della Commissione europea di Minjuvi ® (tafasitamab) per il trattamento del linfoma follicolare recidivante o refrattario
businesswire.com
INCY
Incyte anuncia que la Comisión Europea aprueba Minjuvi ® (tafasitamab) para el tratamiento del linfoma folicular en recaída o refractario
businesswire.com
INCY
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY
Incyte Announces European Commission Approval of Minjuvi ® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
businesswire.com
INCY
UCB’s Bimzelx Continues to Shift Biologic Treatment Patterns in Hidradenitis Suppurativa as Demand for Innovation Grows, According to Spherix Global Insights
globenewswire.com
ABBV
INCY
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
businesswire.com
RPRX
ABBV
NVS
ZURA
INCY
AZN
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
globenewswire.com
INCY
Incyte Announces Change to its Board of Directors
businesswire.com
INCY
Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight
globenewswire.com
TMO
PFE
AMGN
BMY
MRK
DHR
ABBV
GOOG
MSFT
JNJ
MDT
BSX
SYK
EW
ISRG
EMR
BIOX
EXAS
QRVO
TER
ADI
TXN
ON
INTC
NVDA
AMD
HPQ
DELL
IBM
GE
FISV
ADP
PAYX
NOW
CRM
ORCL
SAP
ADSK
CDNS
SNPS
AMAT
INFY
HPE
LOGI
ATHM
BIIB
GILD
REGN
VRTX
AMRN
AZN
LLY
NVS
CRSP
EDIT
NTLA
ALNY
INCY
XRAY
COO
MASI
IRTC
MRNA
EMB
ADMA
ICUI
HOLX
LH
DGX
RDNT
EVTC
AFYA
CHKP
DDOG
SMCI
ALGN
THRY
PTC
MCHP
NXPI
QCOM
SWKS
MU
WDC
STX
Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb
globenewswire.com
MRK
BMY
INCY
AMGN